Compare TXG & TAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXG | TAP |
|---|---|---|
| Founded | 2012 | 1873 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Beverages (Production/Distribution) |
| Sector | Industrials | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 7.3B |
| IPO Year | 2019 | 1994 |
| Metric | TXG | TAP |
|---|---|---|
| Price | $76.56 | $37.87 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 21 |
| Target Price | ★ $67.47 | $45.10 |
| AVG Volume (30 Days) | ★ 3.7M | 3.1M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 5.06% |
| EPS Growth | ★ 76.97 | N/A |
| EPS | N/A | ★ 2.03 |
| Revenue | $245,893,000.00 | ★ $11,723,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.72 | $0.12 |
| P/E Ratio | ★ N/A | $18.68 |
| Revenue Growth | ★ 68.06 | N/A |
| 52 Week Low | $11.17 | $35.52 |
| 52 Week High | $102.81 | $54.82 |
| Indicator | TXG | TAP |
|---|---|---|
| Relative Strength Index (RSI) | 49.13 | 47.02 |
| Support Level | $74.60 | $35.52 |
| Resistance Level | N/A | $43.69 |
| Average True Range (ATR) | 7.16 | 0.97 |
| MACD | -1.48 | 0.18 |
| Stochastic Oscillator | 15.28 | 65.11 |
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Molson Coors owns well-known beer brands including Miller, Coors, Blue Moon, and Carling, and ranks as the second-largest beer maker in both value and volume in the US, Canada, and the United Kingdom. Through licensing agreements, it also brews and distributes beer and nonbeer beverage categories under partner brands from Heineken, Anheuser-Busch InBev, Asahi, Fever-Tree, and Coca-Cola. North America remains its largest market, accounting for nearly 80% of total revenue.